Send to

Choose Destination
Nat Chem Biol. 2009 Nov;5(11):849-56. doi: 10.1038/nchembio.221. Epub 2009 Sep 27.

Chemical genomics in Escherichia coli identifies an inhibitor of bacterial lipoprotein targeting.

Author information

Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.


One of the most significant hurdles to developing new chemical probes of biological systems and new drugs to treat disease is that of understanding the mechanism of action of small molecules discovered with cell-based small-molecule screening. Here we have assembled an ordered, high-expression clone set of all of the essential genes from Escherichia coli and used it to systematically screen for suppressors of growth inhibitory compounds. Using this chemical genomic approach, we demonstrate that the targets of well-known antibiotics can be identified as high copy suppressors of chemical lethality. This approach led to the discovery of MAC13243, a molecule that belongs to a new chemical class and that has a unique mechanism and promising activity against multidrug-resistant Pseudomonas aeruginosa. We show that MAC13243 inhibits the function of the LolA protein and represents a new chemical probe of lipoprotein targeting in bacteria with promise as an antibacterial lead with Gram-negative selectivity.

[Indexed for MEDLINE]

Publication type, MeSH terms, Substances, Secondary source ID, Grant support

Publication type

MeSH terms


Secondary source ID

Grant support

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center